Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysis von Longshaw, Christopher, Santerre Henriksen, Anne, Dressel, Dana, Malysa, Michelle, Silvestri, Christian, Takemura, Miki, Yamano, Yoshinori, Baba, Takamichi, Slover, Christine M

Volltext

Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and Thrive von Safir, M. Courtney, Bhavnani, Sujata M., Slover, Christine M., Ambrose, Paul G., Rubino, Christopher M.

Volltext

Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program von Satlin, Michael J, Simner, Patricia J, Slover, Christine M, Yamano, Yoshinori, Nagata, Tsutae D, Portsmouth, Simon

Volltext

Lactobacillus: a Review von Slover, Christine M., Pharm.D, Danziger, Larry, Pharm.D

Volltext

Cefiderocol For Injection: Compatibility Testing Using the MINI-BAG Plus Container System and the VIAL-MATE Adaptor von Rathod, Dhaval, Chen, Zhengming, Slover, Christine M., Kung, Frank, Morita, Junichi, Nguyen, Sean T.

Volltext

Tigecycline: A Novel Broad-Spectrum Antimicrobial von Slover, Christine M, Rodvold, Keith A, Danziger, Larry H

Volltext

REAL-WORLD EXPERIENCE OF CEFIDEROCOL IN TREATING HOSPITAL-ACQUIRED PNEUMONIA DUE TO GRAM-NEGATIVE PATHOGENS IN THE US HOSPITALS FROM JANUARY 2020 TO JUNE 2022 von CAI, BIN, NGUYEN, SEAN, SONG, HYUNJIN, COPELAND, JENNIFER, SLOVER, CHRISTINE M

Volltext

2753. Real-World Use of Cefiderocol Treating Non-COVID Patients with Confirmed Gram-Negative Infections in US Hospitals During January 2020-June 2022 von Cai, Bin, Zhou, Yun, Slover, Christine M, Copeland, Jennifer D, Nguyen, Sean T

Volltext

2751. Cefiderocol Use in Treating Patients with Confirmed Stenotrophomonas maltophilia Infections in US Hospitals During January 2020 - June 2022 von Cai, Bin, Nguyen, Sean T, Copeland, Jennifer D, Song, Hyun Jin, Slover, Christine M

Volltext

2750. Pseudomonas aeruginosa infections treated with cefiderocol: associations of site of infection and time to first dose with outcomes in PROVE (Retrospective Cefiderocol Chart R... von Marcella, Stephen, Cai, Bin, Friedman, Bruce, Verardi, Stefano, Gozalo, Laurence, Slover, Christine M

Volltext

1715. In Vitro Antibacterial Activity of Cefiderocol against Difficult-to-treat Resistant (DTR) Gram-negative Pathogens in United States from SENTRY Antimicrobial Surveillance Prog... von Yamano, Yoshinori, Takemura, Miki, Shortridge, Dee, Slover, Christine M, Longshaw, Christopher M, Echols, Roger

Volltext

1711. In Vitro Activity of Cefiderocol Against US Achromobacter spp. and Burkholderia spp. Clinical Isolates from the SENTRY Surveillance Program 2020-2021 von Takemura, Miki, Shortridge, Dee, Slover, Christine M, Longshaw, Christopher M, Echols, Roger, Yamano, Yoshinori

Volltext

1734. Susceptibility of Cefiderocol between US Census Regions against Gram-Negative Organisms collected from the SENTRY Surveillance Program: 2020-2021 von Kung, Frank H, Nguyen, Sean, Slover, Christine M, Shortridge, Dee, Streit, Jennifer M, Echols, Roger, Takemura, Miki, Yamano, Yoshinori

Volltext

603. Determining Effect of Media and Disk Source on Reproducibility and Relationship between Broth Microdilution and Disk Diffusion Testing of Cefiderocol von Takemura, Miki, Saiki, Mizue, Yamashiro, Hidenori, Anan, Naomi, DeJonge, Boudewijn L, Slover, Christine M, Longshaw, Christopher M, Henriksen, Anne, Yamano, Yoshinori

Volltext

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes von Brown, Sue A, Forlenza, Gregory P, Bode, Bruce W, Pinsker, Jordan E, Levy, Carol J, Criego, Amy B, Hansen, David W, Hirsch, Irl B, Carlson, Anders L, Bergenstal, Richard M, Sherr, Jennifer L, Mehta, Sanjeev N, Laffel, Lori M, Shah, Viral N, Bhargava, Anuj, Weinstock, Ruth S, MacLeish, Sarah A, DeSalvo, Daniel J, Jones, Thomas C, Aleppo, Grazia, Buckingham, Bruce A, Ly, Trang T

Volltext

Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance von Longshaw, Christopher M, Santerre Henriksen, Anne, Slover, Christine, Yamano, Yoshinori, Karas, J Andreas

Volltext

Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial von Sherr, Jennifer L, Bode, Bruce W, Forlenza, Gregory P, Laffel, Lori M, Schoelwer, Melissa J, Buckingham, Bruce A, Criego, Amy B, DeSalvo, Daniel J, MacLeish, Sarah A, Hansen, David W, Ly, Trang T, Sherr, Jennifer L, Weyman, Kate, Tichy, Eileen, VanName, Michelle, Brei, Michelle, Zgorski, Melinda, Steffen, Amy, Carria, Lori, Bode, Bruce W, Busby, Anna, Forlenza, Gregory P, Wadwa, R Paul, Slover, Robert, Cobry, Erin, Messer, Laurel, Laffel, Lori M, Isganaitis, Elvira, Ambler-Osborn, Louise, Freiner, Emily, Turcotte, Christine, Volkening, Lisa, Schoelwer, Melissa, Brown, Sue A, Krauthause, Katie, Emory, Emma, Oliveri, Mary, Buckingham, Bruce A, Ekhlaspour, Laya, Kingman, Ryan, Criego, Amy B, Schwartz, Betsy L, Gandrud, Laura M, Grieme, Aimee, Hyatt, Jamie, DeSalvo, Daniel J, McKay, Siripoom, DeLaO, Kylie, Villegas, Carolina, MacLeish, Sarah A, Wood, Jamie R, Kaminski, Beth A, Casey, Terri, Campbell, Wendy, Behm, Kim, Adams, Ramon, Hansen, David W, Stone, Sheri L, Bzdick, Suzan, Bulger, Jane, Agostini, Lynn, Doolittle, Sarah, Kivilaid, Kaisa, Kleve, Krista, Ly, Trang T, Dumais, Bonnie, Vienneau, Todd, Huyett, Lauren M, Lee, Joon Bok, O'Connor, Jason, Benjamin, Eric

Volltext

Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes von BUCKINGHAM, Bruce, BECK, Roy W, RUEDY, Katrina J, PEIYAO CHENG, KOLLMAN, Craig, WEINZIMER, Stuart A, DIMEGLIO, Linda A, BREMER, Andrew A, SLOVER, Robert, TAMBORLANE, William V

Volltext